Touboul E, Schlienger M, Buffat L, Lefkopoulos D, Yao X G, Parc R, Tiret E, Gallot D, Malafosse M, Laugier A
Service de Cancérologie-Radiothérapie, Hôpital Tenon, Paris, France.
Radiother Oncol. 1995 Mar;34(3):195-202. doi: 10.1016/0167-8140(95)01522-i.
Between 1973 and 1991, 17 patients with epidermoid carcinoma of the anal margin without evidence of distant metastasis were treated with curative-intent radiation therapy (RT). There were nine T1-tumors, six T2-, one T3- and one T4-tumor; two patients presented with inguinal node involvement: one N1 and one N3. Nine patients underwent prior incomplete local excision (six with microscopic involvement of surgical margins and two with macroscopic residual disease). The radiation dose to the tumor was 60-70 Gy; the radiation dose to the inguinal lymph nodes was 40-45 Gy in N0, and 50-60 Gy for involved inguinal nodes. The 5- and 10-year cancer-specific survival rates were 86.2% and 77.5%, respectively. The same probabilities were 100% and 100% for T1-tumors, 60% and 40% for T2-tumors. Severe complications occurred in two patients, one anal radionecrosis requiring a colostomy and one permanent anal incontinence after local excision, which was non-related to irradiation. For the cured patients, the sphincter preservation rate after 5 years was 82% (9/11). In univariate analysis and in Cox multivariate analysis, the cancer-specific survival rate was influenced by one factor: the tumor size.
1973年至1991年间,17例肛管边缘表皮样癌患者在无远处转移证据的情况下接受了根治性放疗(RT)。其中有9例T1期肿瘤、6例T2期、1例T3期和1例T4期肿瘤;2例患者出现腹股沟淋巴结受累:1例为N1,1例为N3。9例患者之前接受过局部不完全切除(6例手术切缘有显微镜下受累,2例有肉眼可见的残留病灶)。肿瘤的放疗剂量为60 - 70 Gy;腹股沟淋巴结的放疗剂量在N0时为40 - 45 Gy,腹股沟淋巴结受累时为50 - 60 Gy。5年和10年的癌症特异性生存率分别为86.2%和77.5%。T1期肿瘤的相同概率分别为100%和100%,T2期肿瘤为60%和40%。2例患者出现严重并发症,1例为放射性肛门坏死需要行结肠造口术,1例在局部切除后出现永久性肛门失禁,这与放疗无关。对于治愈的患者,5年后括约肌保留率为82%(9/11)。在单因素分析和Cox多因素分析中,癌症特异性生存率受一个因素影响:肿瘤大小。